NEPHSTAR®ULTRASENSITIVECRPKIT
Mexico·Clase I·III. DIAGNOSTIC AGENTS·KABLA COMERCIAL, S.A. DEC.V.·Registered June 16, 2020PARALADETERMINACIÓNCUANTITATIVADELADETECCIÓNULTRASENSIBLEDELAPROTEÍNACREACTIVA(USCRP)HUMANAENSUEROCOMOAYUDAENELDIAGNÓSTICOYTRATAMIENTODEESTADOS INFLAMATORIOS, INFECCIÓNBACTERIANA Y ENFERMEDADES CARDIACAS.PARA USO EXCLUSIVO DE LABORATORIOSCLÍNICOS O DE GABINETES.
FOR THE QUANTITATIVE DETERMINATION OF THE ULTRASENSITIVE DETECTION OF HUMAN ACCREACTIVE PROTEIN (USCRP) IN SERUM AS AN AID IN THE DIAGNOSIS AND TREATMENT OF INFLAMMATORY STATES, BACTERIAL INFECTION AND HEART DISEASE. FOR USE ONLY IN CLINICAL LABORATORIES OR CABINETS.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- PRUEBA PARA LA DETERMINACIÓNCUANTITATIVADEDETECCIÓNDELAPROTEÍNA C REACTIVA (USCRP)
- Trade Name (English)
- TEST FOR THE QUANTITATIVE DETERMINATION OF DETECTION OF C-REACTIVE PROTEIN (USCRP)
- Analysis ID
- 699R2020 SSA
- Registration Date
- June 16, 2020
- Name (Spanish)
- KABLA COMERCIAL, S.A. DEC.V.
- Name (English)
- KABBALAH COMMERCIAL, S.A. DEC.V.
Access comprehensive regulatory information for NEPHSTAR®ULTRASENSITIVECRPKIT (NEPHSTAR®ULTRASENSITIVECRPKIT) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 699R2020 SSA and manufactured by KABLA COMERCIAL, S.A. DEC.V.. The device was registered on June 16, 2020.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.